Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pharmacokinetic Study of Omecamtiv Mecarbil in Heart Failure Patients

This study has been withdrawn prior to enrollment.
(Study cancelled due to sponsor's decision to redesign the study)
Sponsor:
Information provided by:
Amgen
ClinicalTrials.gov Identifier:
NCT01077167
First received: February 25, 2010
Last updated: May 26, 2011
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: May 2011
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)